Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interest of Intravenous Dexmedetomidine (Dexdor®) in the Knee Replacement Surgery Performed Under Locoregional Anesthesia: a Randomized, Double Blind, Controlled Clinical Trial

NCT03834129 is registered in ClinicalTrials.gov with CMC Ambroise Paré as lead sponsor.

NCT NCT03834129
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03834129 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interest of Intravenous Dexmedetomidine (Dexdor®) in the Knee Replacement Surgery Performed Under Locoregional Anesthesia: a Randomized, Double Blind, Controlled Clinical Trial
Lead sponsor
CMC Ambroise Paré
Phase
Phase 3
Overall status
Completed
Start date
May 13, 2019
Completion date
January 11, 2020
Enrollment
94 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary total knee arthroplasty